Early Two-dose Measles Vaccination Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

5,879

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Measles
Interventions
BIOLOGICAL

Measles vaccine

"The children will be randomised to the following three arms:~Arm 1 - Very early two-dose: V (EZ) 4½ mo of age + V (EZ) 9 mo of age.~Arm 2 - 9 months one- or two-dose: V (SW) 9 mo of age + V (SW)/or nothing 18 mo of age.~Arm 3 - 9 months one- or two-dose: V (EZ) 9 mo of age + V (EZ)/or nothing 18 mo of age.~V = measles vaccination, EZ = standard titre Edmonston-Zagreb measles vaccine, SW = standard titre Schwarz measles vaccine"

Trial Locations (1)

1004 Bissau Codex

Bandim Health Project, Bissau

Sponsors
All Listed Sponsors
collaborator

Danish Council for Development Research

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

AP Moeller Foundation

OTHER

collaborator

Medical Research Council Unit, The Gambia

OTHER

lead

Bandim Health Project

OTHER